In the current research, roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations is investigated. The calculation of thickness and optical constants of Iridium (IV) Oxide (IrO2) roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations produced using sol–gel method over glassy medium through a single reflection spectrum is presented. To obtain an appropriate fit for reflection spectrum, the classic Drude–Lorentz model for parametric di–electric function is used. The best fitting parameters are determined to simulate the reflection spectrum using Lovenberg–Marquardt optimization method. The simulated reflectivity from the derived optical constants and thickness are in good agreement with experimental results. The results of optimization algorithm of Lovenberg–Marquardt with physical model of Drude–Lorentz for determining optical constants of Iridium (IV) Oxide (IrO2)–roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations produced using sol–gel method through a single reflection spectrum show that higher doping leads to lower reflectivity and reflection coefficient and also, leads to increase in thickness of thin layer.
| Published in | American Journal of Physical Chemistry (Volume 10, Issue 4) |
| DOI | 10.11648/j.ajpc.20211004.11 |
| Page(s) | 54-58 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Iridium (IV) Oxide (IrO2) Nanoparticles, Cancer Nanobiotechnology, Synchrotron and Synchrocyclotron Radiations
| [1] | A. Heidari, C. Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer Cells”, J Nanomed Res., Volume 2, Issue 5, 20 Pages, 2015. |
| [2] | A. Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles”, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Issue 1, Pages 15–19, 2015. |
| [3] | A. Heidari, “An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertility”, Int J Adv Technol 7: e007, 2016. |
| [4] | A. Heidari, “Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Study”, J Pharmacogn Nat Prod 2: e103, 2016. |
| [5] | A. Heidari, “A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile Complexes”, J Bioeng Biomed Sci S: 006, 2016. |
| [6] | A. Heidari, “Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016. |
| [7] | A. Heidari, “Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J Biomol Res Ther 5: e146, 2016. |
| [8] | A. Heidari, “Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells”, J Bioanal Biomed 8: e135, 2016. |
| [9] | A. Heidari, “A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells”, Adv Cancer Prev 1: e102, 2016. |
| [10] | A. Heidari, “Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles”, J Biotechnol Biomater 6: e125, 2016. |
| [11] | A. Heidari, “A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Study”, J Res Development 4: 144, 2016. |
| [12] | A. Heidari, “Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding”, Biochem Physiol 5: e146, 2016. |
| [13] | A. Heidari, “Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO) Nanoparticles on DNA of Cancer Cells: A Photodynamic Therapy Study”, Arch Cancer Res. 4: 1, 2016. |
| [14] | A. Heidari, “Biospectroscopic Study on Multi–Component Reactions (MCRs) in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugs”, Arch Cancer Res. 4: 2, 2016. |
| [15] | A. Heidari, “Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time–Dependent Bio–Heat Equation and Nd: YAG Lasers”, Arch Cancer Res. 4: 2, 2016. |
| [16] | A. Heidari, “Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res. 4: 1, 2016. |
| [17] | A. Heidari, “Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticles”, J Biomedical Sci. 5: 2, 2016. |
| [18] | A. Heidari, “Measurement the Amount of Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol) and Absorbable Calcium (Ca2+), Iron (II) (Fe2+), Magnesium (Mg2+), Phosphate (PO4–) and Zinc (Zn2+) in Apricot Using High–Performance Liquid Chromatography (HPLC) and Spectroscopic Techniques”, J Biom Biostat 7: 292, 2016. |
| [19] | A. Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer (Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7: e112, 2016. |
| [20] | A. Heidari, “Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniques”, J Drug Metab Toxicol 7: e129, 2016. |
| [21] | A. Heidari, “Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO) Nanoparticles as Anti–Cancer Drug in Formation of Nucleic Acids Complexes for Human Cancer Cells’ Treatment”, Biochem Pharmacol (Los Angel) 5: 207, 2016. |
| [22] | A. Heidari, “A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”, Struct Chem Crystallogr Commun 2: 1, 2016. |
| [23] | A. Heidari, “Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO) Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cells”, Pharm Anal Chem Open Access 2: 113, 2016. |
| [24] | A. Heidari, “A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment”, Chemo Open Access 5: e129, 2016. |
| [25] | A. Heidari, “Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applications”, J Pharmacokinet Exp Ther 1: e005, 2016. |
| [26] | A. Heidari, “Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniques”, Insights Anal Electrochem 2: 1, 2016. |
| [27] | A. Heidari, “Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP) Type Using a Set of Topological Descriptors”, J Heavy Met Toxicity Dis. 1: 2, 2016. |
| [28] | A. Heidari, “Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys. 1: 2, 2016. |
| [29] | A. Heidari, “A Translational Biomedical Approach to Structural Arrangement of Amino Acids’ Complexes: A Combined Theoretical and Computational Study”, Transl Biomed. 7: 2, 2016. |
| [30] | A. Heidari, “Ab Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic Discov 6: e144, 2016. |
| [31] | A. Heidari, “Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”, J Glycobiol 5: e111, 2016. |
| [32] | A. Heidari, “Synthesis and Study of 5–[(Phenylsulfonyl)Amino]–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniques”, Transl Med (Sunnyvale) 6: e138, 2016. |
| [33] | A. Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol 12: 4, 2016. |
| [34] | A. Heidari, “An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acids”, Austin J Anal Pharm Chem. 3 (1): 1058, 2016. |
| [35] | A. Heidari, C. Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC Nanocomposites”, Nano Res Appl. 2: 1, 2016. |
| [36] | A. Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene”, International Journal of Advanced Chemistry, 4 (1) 5–9, 2016. |
| [37] | A. Heidari, “Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues”, Arch Can Res. 4: 2, 2016. |
| [38] | A. Heidari, “Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS) Drugs”, J Data Mining Genomics & Proteomics 7: e125, 2016. |
| [39] | A. Heidari, “Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5) Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two DNA/RNA Molecules of Human Cancer Cells”, J Pharmacogenomics Pharmacoproteomics 7: e153, 2016. |
| [40] | A. Heidari, “Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti–Microbial Drugs: A Clinical Approach”, Transl Biomed. 7: 2, 2016. |
APA Style
Alireza Heidari, Margaret Hotz, Nancy MacDonald, Victoria Peterson, Angela Caissutti, et al. (2021). Iridium (IV) Oxide (IrO2) Nanoparticles and Cancers. American Journal of Physical Chemistry, 10(4), 54-58. https://doi.org/10.11648/j.ajpc.20211004.11
ACS Style
Alireza Heidari; Margaret Hotz; Nancy MacDonald; Victoria Peterson; Angela Caissutti, et al. Iridium (IV) Oxide (IrO2) Nanoparticles and Cancers. Am. J. Phys. Chem. 2021, 10(4), 54-58. doi: 10.11648/j.ajpc.20211004.11
AMA Style
Alireza Heidari, Margaret Hotz, Nancy MacDonald, Victoria Peterson, Angela Caissutti, et al. Iridium (IV) Oxide (IrO2) Nanoparticles and Cancers. Am J Phys Chem. 2021;10(4):54-58. doi: 10.11648/j.ajpc.20211004.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajpc.20211004.11,
author = {Alireza Heidari and Margaret Hotz and Nancy MacDonald and Victoria Peterson and Angela Caissutti and Elizabeth Besana and Jennifer Esposito and Katrina Schmitt and Ling-Yu Chan and Francesca Sherwood and Maria Henderson and Jimmy Kimmel},
title = {Iridium (IV) Oxide (IrO2) Nanoparticles and Cancers},
journal = {American Journal of Physical Chemistry},
volume = {10},
number = {4},
pages = {54-58},
doi = {10.11648/j.ajpc.20211004.11},
url = {https://doi.org/10.11648/j.ajpc.20211004.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpc.20211004.11},
abstract = {In the current research, roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations is investigated. The calculation of thickness and optical constants of Iridium (IV) Oxide (IrO2) roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations produced using sol–gel method over glassy medium through a single reflection spectrum is presented. To obtain an appropriate fit for reflection spectrum, the classic Drude–Lorentz model for parametric di–electric function is used. The best fitting parameters are determined to simulate the reflection spectrum using Lovenberg–Marquardt optimization method. The simulated reflectivity from the derived optical constants and thickness are in good agreement with experimental results. The results of optimization algorithm of Lovenberg–Marquardt with physical model of Drude–Lorentz for determining optical constants of Iridium (IV) Oxide (IrO2)–roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations produced using sol–gel method through a single reflection spectrum show that higher doping leads to lower reflectivity and reflection coefficient and also, leads to increase in thickness of thin layer.},
year = {2021}
}
TY - JOUR T1 - Iridium (IV) Oxide (IrO2) Nanoparticles and Cancers AU - Alireza Heidari AU - Margaret Hotz AU - Nancy MacDonald AU - Victoria Peterson AU - Angela Caissutti AU - Elizabeth Besana AU - Jennifer Esposito AU - Katrina Schmitt AU - Ling-Yu Chan AU - Francesca Sherwood AU - Maria Henderson AU - Jimmy Kimmel Y1 - 2021/10/30 PY - 2021 N1 - https://doi.org/10.11648/j.ajpc.20211004.11 DO - 10.11648/j.ajpc.20211004.11 T2 - American Journal of Physical Chemistry JF - American Journal of Physical Chemistry JO - American Journal of Physical Chemistry SP - 54 EP - 58 PB - Science Publishing Group SN - 2327-2449 UR - https://doi.org/10.11648/j.ajpc.20211004.11 AB - In the current research, roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations is investigated. The calculation of thickness and optical constants of Iridium (IV) Oxide (IrO2) roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations produced using sol–gel method over glassy medium through a single reflection spectrum is presented. To obtain an appropriate fit for reflection spectrum, the classic Drude–Lorentz model for parametric di–electric function is used. The best fitting parameters are determined to simulate the reflection spectrum using Lovenberg–Marquardt optimization method. The simulated reflectivity from the derived optical constants and thickness are in good agreement with experimental results. The results of optimization algorithm of Lovenberg–Marquardt with physical model of Drude–Lorentz for determining optical constants of Iridium (IV) Oxide (IrO2)–roles and applications of Iridium (IV) Oxide (IrO2) nanoparticles in cancer nanobiotechnology using synchrotron and synchrocyclotron radiations produced using sol–gel method through a single reflection spectrum show that higher doping leads to lower reflectivity and reflection coefficient and also, leads to increase in thickness of thin layer. VL - 10 IS - 4 ER -
Information
Email: